Jasper Therapeutics, Inc. (JSPR) vs Medicus Pharma Ltd. Common Stock (MDCX)

A side-by-side comparison of Jasper Therapeutics, Inc. and Medicus Pharma Ltd. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Jasper Therapeutics, Inc. logo
JSPR
Jasper Therapeutics, Inc.
$9M
$0.56HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
Medicus Pharma Ltd. Common Stock logo
MDCX
Medicus Pharma Ltd. Common Stock
$10M
$0.16HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT

Total return — JSPR vs MDCX

growth of $100 · dividends reinvested · last 2y
JSPR -97.3% (-83.6%/yr)MDCX -93.7% (-74.9%/yr)MDCX compounded faster over this window
0100200300Start $10020252026$3$6
JSPR MDCX

JSPR vs MDCX: by the numbers

  • •MDCX is the larger company ($10M vs $9M market cap).

Metrics side by side

Valuation

MetricJSPRMDCX
P/B ratio6.41N/A

Profitability

MetricJSPRMDCX
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-2248.48%N/A
ROIC-1394.09%-269.16%

Growth (annualized)

MetricJSPRMDCX
Total return CAGR (5Y)-62.51%N/A

Go deeper

Full JSPR analysisFull MDCX analysisInteractive comparison tool

Dig into the metrics

Jasper Therapeutics ROEMedicus Pharma Ltd. Common Stock ROEJasper Therapeutics operating marginMedicus Pharma Ltd. Common Stock operating marginJasper Therapeutics revenue growthMedicus Pharma Ltd. Common Stock revenue growthJasper Therapeutics free cash flowMedicus Pharma Ltd. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.